Recent studies show associations between retinal vascular changes and small infarcts detected on brain imaging, or clinical stroke. 1 Fractal dimension has been used as a global measure of the geometric pattern of the retinal vasculature 2,3 potentially representing the complex branching pattern of the microvasculature, including the cerebral microvasculature. We have developed an automatic method to assess spectrum fractal dimension (SFD) of the retinal microvasculature using Fouriertransformed images. 4,5 Two previous studies have reported crosssectional associations between retinal fractal dimension and lacunar stroke. 6, 7 In this study, we aimed to examine the association between baseline SFD and stroke incidence using a case-control sample nested in the Blue Mountains Eye Study (BMES).
Recent studies show associations between retinal vascular changes and small infarcts detected on brain imaging, or clinical stroke. 1 Fractal dimension has been used as a global measure of the geometric pattern of the retinal vasculature 2,3 potentially representing the complex branching pattern of the microvasculature, including the cerebral microvasculature. We have developed an automatic method to assess spectrum fractal dimension (SFD) of the retinal microvasculature using Fouriertransformed images. 4, 5 Two previous studies have reported crosssectional associations between retinal fractal dimension and lacunar stroke. 6, 7 In this study, we aimed to examine the association between baseline SFD and stroke incidence using a case-control sample nested in the Blue Mountains Eye Study (BMES).
Methods. The BMES is a population-based cohort study of an urban population aged 49 years or older (n ϭ 3,654), representing 82.4% of eligible population in a defined area of the Blue Mountains region, Australia. 1 Stroke cases were defined among participants with no past history of stroke at baseline (1992-1994) but who developed stroke during the subsequent 5 years (1997-1999), or who died from stroke or stroke-related causes by late 2005. Detailed definitions of stroke events and mortality are shown in table e-1 on the Neurology ® Web site at www. neurology.org. We identified 130 cases with either a stroke event or stroke-related mortality, and excluded 26 cases who had missing photographs or clinical information, leaving 104 cases for inclusion in this report (21 with stroke event, 86 with strokerelated mortality, and 3 overlapped). Two controls per case were selected and matched for age, gender, diabetes, and hypertension status. Of these, 97.1% (101/104) cases and 88.5% (184/208) controls had baseline retinal photographs of sufficient quality to enable SFD assessment. An area covering 2.5 disc radii from the optic disc center was digitally cropped and enhanced using the Gabor-wavelet transform 6, 7 (figure e-1). The SFD, a mono-fractal in the vessel image spectrum, represents a slope of linear associa-tion between the natural log-scaled image intensity and the natural log-scaled pixel density frequency distribution. 6, 7 This system is fully automated. We performed a Monte Carlo type simulation to assess the reproducibility of image cropping, and found estimates of SFD to be highly correlated on 100 simulated crops (r ϭ 0.93). 7
Standard protocol approvals, registrations, and patient
consents. Written informed consent was obtained from all participants at enrollment for this study. 1 Statistical analysis. We used SFD measures from left eye, given the high correlation between 2 eyes (r ϭ 0.63). We constructed conditional logistic regression models to determine odds ratio (OR) and 95% confidence intervals (CI) for risks associated with each SD decrease or quartile differences in SFD: unadjusted (model 1) or adjusted for stroke risk factors (model 2: body mass index [BMI], smoking, total cholesterol, high-density lipoprotein [HDL] cholesterol, and triglycerides; model 3: plus systolic blood pressure [SBP] and glucose level). Finally, a stepwise-selection method was applied to the variables in model 3.
Results.
Overall, mean age was 73.8 (SD 8.2) years, 58% were female, 49.5% were hypertensive, and 4.6% had diabetes. There were no significant differences in matched or other unmatched characteristics between cases and controls (table e-2). The mean SFD was 1.509 (SD 0.026). Cases had significantly smaller SFD (1.504) compared to controls (1.511; p ϭ 0.04).
Each SD decrease in baseline SFD was associated with 40% greater risk of stroke events (OR 1.39, 95% CI 1.06 -1.83). Persons in the smallest quartile of SFD (Ͻ1.494) were twice as likely to have a subsequent stroke than those in the largest quartile (Ͼ1.527) (stroke incidence 42.3% vs 27.8%; OR 2.30, 95% CI 1.06 -4.97) (table 1) . This association remained significant after adjusting for BMI, smoking, total cholesterol, HDL cholesterol, and triglycerides (model 2: OR 2.42, 95% CI 1.04 -5.62), or further adjusting for SBP and glucose (model 3: OR 2.43, 95% CI 1.04 -5.68). Using a stepwise backward selection method, per SD decrease in the SFD was the only factor that retained statistical significance.
Supplemental data at www.neurology.org
Discussion. We found that low SFD of retinal vasculature was associated with 2-fold higher risk of incident stroke events compared to persons with high SFD, independent of stroke risk factors. Limitations of our study include potential selection bias from excluding cases with poor quality images, and the lack of stroke subtype information.
While our study supports the concept that structural change in the retinal microvasculature may represent a subclinical biomarker of risk for stroke, what the specific changes indicate in the context of stroke pathogenesis remains unclear. We speculate that reduced SFD indicates reduced complexity in the branching pattern of the microvasculature, leading to reduced perfusion and limited ability to form collaterals, which could increase vulnerability to hypoxia. Routine hematology, thyroid function, vitamin E, B12, and copper studies were normal. CSF examination revealed normal protein content, cell count, and no oligoclonal bands. Urinary amino and organic acids, hexosaminidase, and acylcarnitines were normal. Echocardiography was normal. An EEG showed a mild generalized increase in slow wave activity and occasional sharply contoured theta waves in the right frontotemporal region. Nerve conduction studies revealed a mild, length-dependent sensorimotor polyneuropathy. Genetic studies were negative for Friedreich ataxia, spinocerebellar ataxia 1, 2, 3, 6, 7, and 17, dentatorubropallidoluysian atrophy (DRPLA), and the fragile X tremor-ataxia syndrome.
Muscle biopsy showed occasional atrophic fibers, but no cytochrome oxidase deficient fibers or ragged red fibers. Long-range PCR detected full-length normal mitochondrial DNA in skeletal muscle. Electron microscopy revealed the presence of occasional subsarcolemmal clusters of enlarged mitochondria containing paracrystalline inclusions.
Brain MRI at age 51 (figure) showed high signal on T2-weighted images in the white matter of both hemispheres, thalami, midbrain, and pons with associated brainstem atrophy. There was also extensive cortical thickening in the right frontal lobe with abnormal enhancement after IV contrast. By 51 years of age, the cortical thickening had resolved, leaving frontal atrophy.
Very long chain fatty acids analysis revealed normal C22:0, C24:0, and C26:0 levels and ratios, but elevated levels of phytanic (14.7 mol/L, normal 0.3-11.5 mol/L) and pristanic (75.9 mol/L, normal 0.0 -1.5 mol/L) acids, suggesting a disorder of peroxisomal fatty acid oxidation. Plasma bile acid analysis revealed normal levels of deoxycholic acid Discussion. AMACR deficiency is a rare cause of relapsing encephalopathy, with only 4 previously published clinical descriptions. [1] [2] [3] The case described here is unusual because of the predominant cerebellar presentation, with a dysarthria described as a late feature in only one other patient. 1 Seizures are unusual in late-onset degenerative ataxias. Potential causes include DRPLA, spinocerebellar ataxia type 10, episodic ataxia type 2, and neurometabolic disorders including mitochondrial diseases. If we include the patient described here, seizures have now been described in 80% of patients of AMACR deficiency. In 2, the first seizure occurred after age 50. Our observations stress the importance of measuring phytanic and pristanic acid levels in patients with unexplained ataxia when there are additional features such as epilepsy, even when there is not an obvious retinopathy or deafness (which would be expected in Refsum disease). It is not clear how elevated phytanic acid levels cause neural cell death, but the mechanism may be mediated through an effect on oxidative phosphorylation, and the supply of ATP. 4 This may explain why the clinical presentation and imaging findings in our patient are reminiscent of mitochondrial disorders, which underpin a growing group of recessive cerebellar ataxias. 5 It is intriguing that there was no objective cognitive decline in our patient over a 7-year period, despite the progressive ataxia. This contrasts with other cases, where the cognitive decline was prominent and progressive. This emphasizes the importance of di-David Dick, MD Rita Horvath, MD, PhD Patrick F. Chinnery, FMedSci etary modifications aimed at reducing phytanic acid and pristanic acid levels, which may prevent clinical progression. 6 
